Our Patient Testimonials Give an Insiders' View of Our Cancer Treatments
Dear Friend,
When it comes to cancer treatment at Issels®, no one can speak about it more eloquently than our patients. Here's what they have to say in their testimonials about our integrative immunotherapy programs.
In Our Patients' Own Words: The Issels® Difference
- Gerhard Uhlemann was diagnosed with an epipharynx tumor of the head and neck. As he explains, "I was 12 years old and I am still thankful that Dr. Issels saved my life. Back then the University Clinic gave me two weeks to live." After treatment, Uhlemann remained cancer-free for more than 30 years.
- At the age of six, Emma Banks was diagnosed with a Wilms tumor. Two years after a nephrectomy of her left kidney, Emma experienced a relapse with two tumors in her left lung. Emma's mother Susan relates that, thanks to treatment at Issels®, her daughter "has been in remission for almost nine years now without any standard treatment."
- When Kenneth Scoones lost his lymph nodes to melanoma, he was told the cancer had metastasized to his lungs and his life expectancy was one year at most. After four weeks at Issels®, a CT scan revealed that the metastases had disappeared. Scoones states that from his arrival, "The doctors, nurses, all the staff responded, showed care and affection, and compassion – everything that was needed for a patient with this sort of disease."
Immunotherapy: Going Beyond Standard Cancer Treatment
Our innovative immunotherapy methods boost the natural power of your body's own immune system. Contact us to learn more about cancer vaccines, NK cells and other non-toxic cancer treatments at Issels®.
 |
|
|
Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »
|
|
|
|
The Cost of Some New Cancer Drugs Spiral Out Of Reach for Some Patients
During the 10-year period between 2005 and 2015, Big Pharma's pipeline of cancer drugs increased by 63 percent, with several reaching the market. As a result, the global market is projected to grow from $16.9 billion in 2015 to an astounding $75.8 billion in 2022.
But while competition generally serves to drive prices down, that's not happening with the new cancer drugs. Factors such as market exclusivity, insurance plan structures and lack of head-to-head comparison studies combine to keep prices high.
Major Growth in Immunotherapy for Cancer Expected Before 2020
Immunotherapy works to remove the "shield" around cancer cells and help the immune system do its job. Cancer immunotherapy treatments are created to specifically target cancer cells, so they have been useful against increasingly diverse forms of cancer. Immunotherapy has fewer side effects than traditional treatments such as chemotherapy and radiation. Many immunotherapy treatments have proved to be successful, encouraging continued research and development.
Videos – What Do Patients Say About Their Experience?
Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.
|
|
|
|
|
|
